HYCO-3的免疫调节作用,是一种双重作用的CO释放器/Nrf2激活器
Goran Stegnjaić1, Neda Nikolovski1, Suzana Stanisavljević1
1Department of Immunology, Institute for Biological Research 'Siniša Stanković' - National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
释放一氧化碳 (CO) 的混合分子 (HYCO) 显示出治疗自身免疫性疾病的前景. 从多发性硬化症的动物模型中,HYCO-3有效降低了免疫细胞中的炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 混合分子 (HYCOs) 将Nrf2激活剂与一氧化碳 (CO) 释放组结合起来.
- HYCOs模仿血红氧酶-1 (HO-1) 活性,这是一个由Nrf2调节的细胞保护酶.
- 在实验性自身免疫性脑膜炎 (EAE) 中,HYCOs已经证明了治疗潜力,这是多发性硬化症的一个模型.
研究的目的:
- 在自身免疫性疾病模型中研究HYCO-3的免疫调节机制.
- 评估HYCO-3对AEE中髓状干细胞,微质细胞和T淋巴细胞的影响.
主要方法:
- 利用了EAE免疫小鼠的骨髓原细胞,微质细胞和T淋巴细胞.
- 向这些免疫细胞群体施用HYCO-3.
- 测量了促炎性细胞因子和氧化的产生.
- 评估细胞的抗原呈现能力.
主要成果:
- 在所有测试的细胞类型中,HYCO-3表现出显著的免疫调节作用.
- 观察到抑制促炎性细胞因子和氧化生产.
- 对抗原呈现细胞容量的下调是一个关键发现.
结论:
- HYCO-3显示出强大的抗炎和免疫调节特性.
- 这些发现支持HYCOs作为自身免疫和慢性炎症疾病的潜在治疗剂.
- 进一步开发HYCOs来治疗炎症疾病是有必要的.
更多相关视频
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
相关概念视频
Co-activators and Co-repressors
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Regulation of Hematopoietic Stem Cells
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
